For the Quarter Ending June 2025
North America
• The North American region experienced an overall downward trend in Amino acid spot prices through Q2 2025, with an average price decline of roughly 5.22%. Spot prices softened from USD 1,320/MT in April to USD 1,190/MT in May, rebounding slightly by June, reflecting a tentative recovery after two months of contraction.
• Throughout the quarter, the Amino acid spot price remained under si*gnificant pressure as oversupply, sluggish end-user demand in the dietary and food sectors, and cautious inventory management dominated market behavior.
• The Amino acid production cost trend within Q2 showed marginal downward movement, with softening global energy costs and unfavorable demand supporting minimal raw material price inflation; still, the abundance of inventories forced producers to aggressively re-evaluate their pricing strategy.
• U.S. buyers shifted to on-demand procurement approaches, exacerbating limited purchasing activity. The existing stockpiles carried over from Q1 and improved logistics discouraged forward buying, and transactional urgency was minimal.
• On the Amino acid demand outlook side, both animal feed and nutraceutical applications in North America witnessed reduced procurement. Livestock feed producers slowed buying due to high inventories, while food and nutraceutical buyers prioritized inventory reduction rather than fresh procurement.
• In June 2025, the Amino acid market staged a modest rebound, with spot prices rising to 1,235 on the back of a pick-up in downstream demand from pharmaceutical and personal care sectors driven by seasonal production and restocking. Buyers gained renewed confidence as logistics improved and the supply chain normalized.
• International Amino acid suppliers from Asia intensified export efforts throughout Q2, leveraging improved logistics and reduced freight rates to increase material available at U.S. ports. This competitive import dynamic, along with partial tariff offsets, kept the landed cost of imports lower, further undercutting domestic offers.
• While port congestion and container shortages were noted early in the quarter, by June, supply chains on the West Coast were notably more efficient, enabling importers to confidently rebuild inventories even as the U.S. dollar weakened and feedstock volatility persisted.
• The Amino acid price forecast for the next quarter suggests continued cautious optimism; as global market sentiment improves and supply begins to tighten, prices are expected to remain steady or edge modestly higher, with inventory carryovers and competitive global trade activity acting as key wild cards.
• Moving forward, strategic hedging, heightened supply-side discipline, and steady to growing health and nutrition applications are expected to frame North America's Q3 Amino acid market performance.
APAC
• APAC saw a downward quarterly trend in Amino acid spot prices, with the average price dropping by approximately 3.81%. Spot prices fell from 1,843.16 in April to 1,589.61 in June, including an 11.2% decline from April to May and an additional 2.8% drop into June.
• The Amino acid spot price surge in April was driven by global supply disruptions, rising raw material costs (especially corn and soy), and robust demand from pharmaceutical and animal feed sectors, amplified by the pre-monsoon restocking cycle in India.
• The Amino acid production cost trend within the quarter was mixed; April’s cost inflation from high input prices and currency depreciation was offset by May and June’s cooling cost environment as supply chain enhancements and stable operational costs prevailed, despite ongoing geopolitical uncertainty.
• Strong Amino acid demand persisted in April and was linked to heightened output in pharma, nutraceuticals, and feed, though it moderated significantly by late Q2 due to inventory normalization, economic uncertainty, and a more cautious business climate.
• By May, modest decreases in Amino acid spot price were observed as inventories built up, manufacturing outpaced consumption, and traders adopted a cost-control focus, leading to advance order reduction and short-order cycles.
• In June 2025, Amino acid spot prices continued to slide as oversupply persisted both globally and domestically, with subdued procurement and conservative buying strategies dominating market activity. Import challenges and high inventory dampened prospects for rapid price recovery, particularly for feed-grade variants.
• Regional manufacturing maintained solid operating rates, but with reduced capacity utilization in India and Southeast Asia by June due to sluggish offtake and high stocks. The continued flow of international material from China sustained supply discipline pressures.
• On the Amino acid demand outlook, end-use sectors like livestock, food processing, and pharma reduced new purchases, favoring "just-in-time" procurement amid price uncertainty. Poultry and swine feed segments, in particular, saw notable pullbacks due to climatic and cyclical market effects.
• The Amino acid price forecast for the next quarter anticipates stabilized spot prices as supply overflow abates and production aligns closer with reduced demand. Manufacturers may act to curtail output should persistent low prices threaten margins, though any rebound is expected to be gradual.
• Policy watch, shifting trade patterns, and any further improvement in end-user industrial confidence will influence price trajectories through Q3 in APAC.
Europe
• The European Q2 2025 Amino acid market landscape largely mirrored APAC’s downward overall quarterly trend, reflecting a stable-to-soft market tone after prior relative resilience. The average spot price movement was moderately negative, with June spot prices broadly steady to lower as in APAC.
• Amino acid spot price offers for Europe remained subdued through most of Q2, with only isolated stabilizations seen as global prices (notably FOB China) started to firm slightly by late June. The strong EUR offset some imported inflation, containing the spot price impact for end-users.
• The Amino acid production cost trend within the second quarter remained relatively stable, with European producers less exposed to feedstock volatility compared to Asia. Input cost containment and consistent logistics flowed from Europe’s mature production base and diversified sourcing strategies.
• Amino acid demand outlook within Q2 stayed cautious, as animal feed, food, and pharmaceutical sectors moderated procurement volumes in the face of steady supply and persistent stockpiles. Feed-grade Lysine and Methionine, major contributors to continental Amino acid usage, saw minimal volume growth.
• In June 2025, European spot prices experienced only slight upward pressure as Chinese and Southeast Asian supply readjustments narrowed the global surplus, coupled with periodic manufacturer shutdowns and port disruptions that temporarily disrupted the flow of imports.
• European spot prices have remained stubbornly low, resulting in Q2 and early Q3 contract buying and even some forward purchases by risk-averse end-users hoping to lock in advantageous terms while market fundamentals remain weak.
• Regulatory backdrop, especially EFSA’s continued vigilance and national food safety oversight, ensured disciplined Amino acid quality and availability but also resulted in a slow pipeline for new applications or grade diversification.
• The Amino acid price forecast for the next quarter calls for gentle stabilization or a muted correction upward as both APAC and U.S. excess inventory dissipates and local buyers gradually increase off-take, anticipating possible global market tightening in Q3.
• Amino acid production cost discipline will be reinforced as more manufacturers pursue intermittent planned shutdowns; further optimization of European production facilities is expected during the peak summer months to balance market and supply-side economics.
• The Amino acid demand outlook for Q3 will benefit from gradual recovery in livestock, food, and health nutrition sectors, but pronounced price increases are unlikely unless either raw material costs or global trade flows experience unexpected disruption.
For the Quarter Ending March 2025
North America
In Q1 2025, U.S. market dynamics for Amino Acid saw notable price fluctuations, reflecting broader market instability. January started with an increase in prices, driven by stockpiling as consumers anticipated potential supply chain disruptions. This uptick was also fueled by a seasonal surge in demand, particularly from downstream industries that rely on Amino Acid for production. Additionally, the cold winter months, along with logistical challenges caused by snowstorms and freezing temperatures, contributed to procurement delays.
In February and March, however, prices began to decline. As the winter weather cleared and logistical bottlenecks were resolved, the urgency to secure supplies lessened. With fewer supply chain disruptions and a reduction in downstream demand as stockpiling eased, the market adjusted accordingly. March saw continued price declines, driven by reduced urgency among buyers and some destocking activities.
Overall, the price trends for Amino Acid in the U.S. during Q1 2025 were characterized by initial volatility, followed by a decline as supply chain conditions normalized and downstream demand stabilized. Weather disruptions and shifts in buying activity, including adjustments from downstream industries, contributed to the fluctuations observed throughout the quarter.
Asia Pacific
In Q1 2025, the Indian Amino Acid market experienced a steady and persistent price increase, driven by strong demand and ongoing supply constraints. January marked the beginning of this trend, fueled by rising demand from the livestock and poultry sectors due to seasonal nutritional adjustments, while suppliers grappled with production issues, logistical delays, and inventory destocking. Additionally, rising quotations in neighboring regions and the depreciation of the Indian Rupee against the US Dollar further boosted export competitiveness and cost pressures.
In February, the bullish trend continued as limited inventories, higher regional export prices, and increased storage costs pushed prices further upward. The weakened Rupee sustained elevated export prices, reinforcing a supplier’s market. By March, the market saw additional price support as livestock feed demand surged in preparation for the hotter months, driving consumption of amino acids like Threonine, Lysine, and Methionine.
Throughout the quarter, the demand side consistently outpaced supply, and market dynamics remained favorable for sellers. Overall, Q1 2025 was marked by tight supply, strong feed sector demand, and upward price momentum, with expectations of continued firm pricing in the near term.
Europe
In Q1 2025, the European market for Amino Acid experienced notable price fluctuations, influenced by a mix of supply disruptions, shifts in downstream demand, and rising import costs. January saw a price increase, driven by a surge in demand from downstream sectors, particularly the food and beverage industries, where Amino Acid is essential for fortification and production. This was coupled with logistical challenges, including high freight costs and delays, which pushed prices higher as importers secured stock ahead of anticipated supply shortages.
However, by February and March, prices began to decline. As the initial surge in demand stabilized and supply chain disruptions eased, the urgency to secure larger quantities lessened. The warmer weather and improved logistics helped resolve some of the earlier transportation delays. Additionally, some destocking occurred as buyers adjusted to the market conditions, further driving prices down. Despite continued demand from key sectors like pharmaceuticals and animal feed, the market corrected after the initial price spike in January, resulting in a gradual decrease in prices through February and March.
Overall, Amino Acid prices in Europe showed a pattern of initial increases in January, followed by a decline in February and March. The market dynamics were shaped by supply chain adjustments, fluctuations in downstream demand, and import cost variations, with a generally more stable outlook expected for the upcoming months as the market finds balance.
For the Quarter Ending December 2024
North America
During the entire the fourth quarter of 2024, the U.S. amino acids market witnessed fluctuating dynamics, marked by varying demand and shifting price trends.
Early in October, the market saw upward pressure on prices due to heightened demand from the animal nutrition sector, spurred by seasonal requirements for better feed quality. However, logistical issues and production setbacks ahead of the holiday season led to supply shortages, exacerbating the price increase. As November progressed, the market experienced a slowdown. Demand from key sectors, such as dietary supplements and animal feed, softened, prompting manufacturers to reduce prices. With the drop, an oversupply situation lingered, with many downstream industries holding onto excess inventory. The cautious buying behaviour of end-users, awaiting further price adjustments, led to lower trading volumes.
By December, the market shifted towards a more positive outlook. Price increases were driven by stronger demand from the pharmaceutical and food industries, coupled with rising feed costs. This created a favourable environment for suppliers, while improved purchasing strategies from buyers helped drive up market activity. The combination of strong export demand and heightened profit margins benefited traders, especially as the year closed with more stable pricing patterns.
APAC
In the fourth quarter of 2024, the Indian market for amino acids experienced mixed trends, reflecting both challenges and opportunities. October saw significant price hikes driven by increasing demand from the livestock and poultry sectors, which required higher nutritional intake due to seasonal changes. However, logistical hurdles and production disruptions ahead of the festive season restricted supply, causing a supply-demand imbalance that pushed prices up. Furthermore, the depreciation of the Indian Rupee provided an advantage for exporters, enhancing trade competitiveness. Moving into November, the market took a more subdued turn. Demand weakened across key industries, including animal nutrition and dietary supplements. Manufacturers responded by lowering prices slightly, but the market remained oversupplied, with downstream industries holding ample stock. Buyers were cautious, hesitant to restock as they awaited potential further price reductions. This phase was characterized by lower transaction volumes and sluggish trading activity, indicating a pause in market momentum. Lastly, By December, the Indian Amino acid market exhibited strong bullish momentum. The price rally was particularly evident in India's western and northern industrial hubs, supported by heightened demand from the pharmaceutical and food industries. Rising feed corn prices provided additional cost support, creating a supplier-favourable market while buyers maintain aggressive procurement strategies to secure volumes to prevent ahead of the festive season, benefiting the traders in terms of higher export prices and heighten profit margins.
Europe
In Q4 2024, the German amino acids market displayed a mixed performance due to various domestic and international factors. October witnessed a notable price increase driven by robust demand from the livestock and poultry industries, where seasonal shifts led to higher nutritional requirements. However, logistical disruptions and production issues related to the upcoming holiday season created supply shortages, amplifying the supply-demand imbalance and pushing prices higher. Additionally, the depreciation of the euro bolstered export competitiveness, benefiting trade dynamics. November saw a cooling in demand, especially in animal nutrition and dietary supplements, leading to reduced pricing pressures. Despite this, the market remained oversupplied, with downstream sectors holding substantial inventories. Caution prevailed among buyers, who refrained from restocking in anticipation of further price declines. Trading volumes were subdued, reflecting a temporary pause in market activity. By December, the market shifted back into a bullish trend, fueled by increased demand from the pharmaceutical and food sectors. Rising corn feed prices contributed additional cost support, benefiting suppliers. In response, aggressive procurement strategies among buyers helped to secure favorable volumes, boosting export prices and profit margins for traders.
For the Quarter Ending September 2024
North America
In the third quarter of 2024, the North American region experienced stable prices for Amino acids, with notable fluctuations in the USA market. Several factors influenced market dynamics, including abundant supply, weak demand, and subdued consumption patterns. The oversupply situation, along with reduced trading activity, contributed to price declines.
Suppliers responded to lower new orders by scaling back production, resulting in shortening supplier lead times. End-users adopted a cautious purchasing strategy focused on necessity, further dampening overall buying interest. Despite some optimism tied to strategic sales efforts, market sentiment remained weak due to the ongoing surplus and reduced demand.
The USA experienced the most significant price changes during the quarter, marked by challenges related to limited inventory and rising prices. Increased demand from downstream industries and positive market sentiment drove prices higher, while slight fluctuations in the pricing environment persisted. By the end of Q3, the USA Amino acid market saw a significant price increase, primarily due to heightened demand in both domestic and export markets, compounded by declining inventory levels and robust end-user consumption. Overall, despite witnessing an optimistic trajectory, the overall market witnessed a pessimistic trajectory with supply
APAC
In the third quarter of 2024, the amino acid market in the APAC region demonstrated overall stability, with periods of notable price fluctuations driven primarily by dynamics in China. Early in the quarter, amino acid prices surged, propelled by increased demand from sectors such as animal feed, pharmaceuticals, dietary supplements, and food additives. Supply chain disruptions, production challenges, and global demand pressures contributed to this upward price trend. Key industries like poultry and aquaculture, reliant on amino acids for growth and health, felt the impact, as did pharmaceutical companies facing elevated production costs due to rising energy, feed, and labor expenses. However, August saw a sharp price decline. The appreciation of the Chinese yuan against the US dollar reduced arbitrage opportunities and bolstered domestic supply, which weakened global competitiveness. Geopolitical tensions and rising freight costs further disrupted trade, and seasonal manufacturing shutdowns resulted in inventory liquidation, particularly for heat-sensitive amino acid products. As the quarter progressed, prices rebounded sharply. Supply shortages and rising demand, especially with the approach of the festive season, fueled proactive buying and heightened competition. The reopening of production facilities and concerns over potential shortages increased the urgency in procurement. Supply chain disruptions and higher phosphoric acid costs exacerbated market conditions, leading to reduced inventories and higher prices by the end of the quarter. The stronger yuan further bolstered the competitiveness of Chinese exports. Overall, the market sentiments concerning amino acids witnessed a downward trajectory throughout the quarter with the supply side outspacing the demand side.
Europe
In Q3 2024, the European amino acid market experienced a dynamic pricing environment shaped by supply-demand imbalances, economic pressures, and strategic inventory management. The quarter began with stable prices, particularly in Germany, where robust bulk purchasing and limited stock availability drove price increases in July. However, by August, prices dropped significantly across the region due to a combination of reduced production costs, lower energy expenses, and oversupply resulting from weakened demand in key sectors. This surplus led to intensified destocking efforts by companies aiming to clear inventories, further exacerbating the supply glut.
Germany, the region’s most volatile market, saw a mixed economic outlook during the quarter, with challenges in its manufacturing sector and signs of easing inflation. Despite these factors, demand in critical end-use sectors remained subdued, contributing to the overall downward price trend. By late September, prices began to rebound as escalating storage costs and the risk of product degradation prompted companies to offload amino acid inventories. Additionally, rising quotations from end-users and traders’ efforts to stabilize cash flow helped lift prices toward the end of the quarter.
Overall, while Q3 2024 saw considerable fluctuations in the European amino acid market, the period ended with a consistent downward price trend despite short-term rebounds driven by inventory management strategies.
FAQ:
1. What is the current price trend of Amino Acids in North America?
In Q2 2025, the North American Amino Acid market witnessed an overall price decline of approximately 5.22%. Spot prices dropped from 1,320 in April to 1,190 in May, before recovering modestly to 1,235 in June, as downstream demand from pharmaceutical and personal care sectors improved late in the quarter.
2. Who are the top global producers of Amino Acids?
Key global producers of Amino Acids include Ajinomoto (Japan), Evonik Industries (Germany), CJ CheilJedang (South Korea), ADM (USA), and Meihua Group (China). These companies maintain large-scale production capacities and strong distribution networks across pharmaceuticals, nutraceuticals, and animal feed segment
3. What are the main reasons behind the price drop in APAC and Europe during Q2 2025?
In both APAC and Europe, Amino Acid prices declined due to high inventory levels, oversupply, and moderated demand across livestock and food sectors. While APAC faced reduced capacity utilization, Europe’s prices remained under pressure due to subdued demand and persistent stockpiles, despite more stable production costs.
4. What is the market outlook for Amino Acids in Q3 2025?
The Q3 2025 forecast suggests cautious stabilization in Amino Acid prices across all regions. While inventory overhangs and slow demand recovery may suppress sharp price gains, improved logistics, reduced global surplus, and supply-side discipline could support modest price recovery, particularly in pharmaceutical and nutritional segments.
